Read by QxMD icon Read

Thank You for Smoking

shared collection
48 papers 0 to 25 followers Increasing smoking cessation treatment for primary care and psychiatric patients
By Edwin Kim Resident Physician, Aspiring Addiction Psychiatrist
Jennifer S Haas, Jeffrey A Linder, Elyse R Park, Irina Gonzalez, Nancy A Rigotti, Elissa V Klinger, Emily Z Kontos, Alan M Zaslavsky, Phyllis Brawarsky, Lucas X Marinacci, Stella St Hubert, Eric W Fleegler, David R Williams
IMPORTANCE: Widening socioeconomic disparities in mortality in the United States are largely explained by slower declines in tobacco use among smokers of low socioeconomic status (SES) than among those of higher SES, which points to the need for targeted tobacco cessation interventions. Documentation of smoking status in electronic health records (EHRs) provides the tools for health systems to proactively offer tobacco treatment to socioeconomically disadvantaged smokers. OBJECTIVE: To evaluate a proactive tobacco cessation strategy that addresses sociocontextual mediators of tobacco use for low-SES smokers...
February 2015: JAMA Internal Medicine
K T McVary, S Carrier, H Wessells
PURPOSE: We examined available evidence concerning the role of smoking in the development of erectile dysfunction. This task involved a complete review of the smoking literature as it pertained to erectile dysfunction and select endothelial diseases. MATERIALS AND METHODS: We comprehensively reviewed the literature, including PubMed and recent abstract proceedings from national meetings relevant to smoking, erectile dysfunction and endothelial diseases. The quality of the evidence was assessed by methods used to develop clinical practice guidelines...
November 2001: Journal of Urology
Montse Ballbè, Gemma Nieva, Sílvia Mondon, Cristina Pinet, Eugeni Bruguera, Esteve Saltó, Esteve Fernández, Antoni Gual
INTRODUCTION: Smoke-free policies have been extended to enclosed workplaces in many countries; however, smoking continues to be commonly allowed on psychiatric premises. The aim of this study was to describe tobacco control strategies undertaken in psychiatric inpatient services and day centres in Spain. METHODS: This cross-sectional survey included all psychiatric service centres that offered public services in Catalonia, Spain (n=192). Managers responded to a questionnaire of 24 items that covered four dimensions, including clinical intervention, staff training and commitment, smoking area management and communication of smoke-free policies...
November 2012: Tobacco Control
Alex J Mitchell, Davy Vancampfort, Marc De Hert, Brendon Stubbs
BACKGROUND: Prevalence rates of smoking in people with mental illness are high, and premature mortality attributed to tobacco related physical comorbidity is a major concern. We conducted a meta-analysis comparing rates of receipt of smoking cessation advice among people with and without mental illness. METHOD: Major electronic databases were searched from inception till August 2014 for studies comparing rates of receipt of smoking cessation advice of people with and without a mental illness...
January 2015: General Hospital Psychiatry
Aniyizhai Annamalai, Noreen Singh, Stephanie S O'Malley
Smoking rates in people with serious mental illness (SMI) are disproportionately high compared to the general population. It is a leading contributor to the early mortality in this population. Smoking cessation rates are low in this group, though patients are motivated to quit. Unfortunately, health care providers do not always prioritize smoking cessation for this population. This review provides an overview of prevalence rates, biological effects that maintain smoking, and evidence-based treatments for smoking cessation in SMI...
September 2015: Yale Journal of Biology and Medicine
Emmert Roberts, A Eden Evins, Ann McNeill, Debbie Robson
BACKGROUND AND AIMS: To assess the efficacy and tolerability of adjunctive pharmacotherapy for smoking cessation in adults with serious mental illness (SMI) by means of a systematic review and network meta-analysis. METHOD: We searched Embase, Medline, PsychINFO and the Cochrane Central Register of Controlled Trials from database inception to 1 December 2014 for randomized controlled trials (RCTs) published in English. We included all studies of smokers with SMI (including schizophrenia, schizoaffective disorder, bipolar disorder, delusional disorder and depressive psychoses) who were motivated to quit smoking...
April 2016: Addiction
Judith J Prochaska, Sebastien C Fromont, Kevin Delucchi, Kelly C Young-Wolff, Neal L Benowitz, Stephen Hall, Thomas Bonas, Sharon M Hall
OBJECTIVE: Individuals with serious mental illness (SMI) are dying on average 25 years prematurely. The leading causes are chronic preventable diseases. In the context of a tobacco-treatment trial, this exploratory study examined the behavioral risk profiles of adults with SMI to identify broader interventional needs. METHOD: Recruited from five acute inpatient psychiatry units, participants were 693 adult smokers (recruitment rate = 76%, 50% male, 45% Caucasian, age M = 39, 49% had income < $10,000) diagnosed with mood disorders (71%), substance-use disorders (63%), posttraumatic stress disorder (39%), psychotic disorders (25%), and attention deficit-hyperactivity disorder (25%)...
December 2014: Health Psychology: Official Journal of the Division of Health Psychology, American Psychological Association
Emma E McGinty, Julia Baller, Susan T Azrin, Denise Juliano-Bult, Gail L Daumit
People with serious mental illness (SMI) have mortality rates 2 to 3 times higher than the overall US population, largely due to cardiovascular disease. The prevalence of cardiovascular risk factors such as obesity and diabetes mellitus and other conditions, such as HIV/AIDS, is heightened in this group. Based on the recommendations of a National Institute of Mental Health stakeholder meeting, we conducted a comprehensive review examining the strength of the evidence surrounding interventions to address major medical conditions and health-risk behaviors among persons with SMI...
January 2016: Schizophrenia Bulletin
Marc L Steinberg, Jill M Williams, Naomi F Stahl, Patricia Dooley Budsock, Nina A Cooperman
INTRODUCTION: Smokers with serious mental illness (SMI) have a high smoking prevalence and a low quit rate. Motivational interviewing (MI) is an empirically supported approach for addressing substance use disorders and may motivate smokers with SMI to quit. METHODS: We randomized smokers (N = 98) with SMI to receive a single 45-minute session of (1) MI with personalized feedback or (2) interactive education. We hypothesized that participants receiving the MI intervention would be more likely to follow-up on a referral for tobacco dependence treatment, to make a quit attempt, and to quit smoking than those receiving the interactive educational intervention...
March 2016: Nicotine & Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco
Britta Wigginton, Coral Gartner, Ingrid J Rowlands
INTRODUCTION: Electronic cigarette (e-cigarette) use, or vaping, is increasing against a backdrop of declining smoking rates. E-cigarettes contain fewer toxicants than cigarettes, but their appearance and mode of use has the potential to satisfy the habitual aspects of smoking. To date, we know little about lay perceptions of the safety of using e-cigarettes in pregnancy. METHODS: We conducted a thematic discourse analysis of 13 online discussion forum threads that discussed e-cigarette use during pregnancy...
January 2017: Women's Health Issues: Official Publication of the Jacobs Institute of Women's Health
Anuradha Gorukanti, Kevin Delucchi, Pamela Ling, Raymond Fisher-Travis, Bonnie Halpern-Felsher
E-cigarette use has dramatically increased. While studies have examined adolescents' attitudes towards smoking, few have extended this research to adolescents' attitudes towards e-cigarettes. The goal of this study was to examine adolescents' attitudes regarding e-cigarette ingredients, safety, addictive properties, social norms, accessibility, price, and regulation; and determine whether attitudes differ by past cigarette/e-cigarette use. Participants were 786 9th and 12th graders from California (63.21% females; mean age=16...
January 2017: Preventive Medicine
Leighton Ku, Erin Brantley, Tyler Bysshe, Erika Steinmetz, Brian K Bruen
INTRODUCTION: State Medicaid programs can cover tobacco cessation therapies for millions of low-income smokers in the United States, but use of this benefit is low and varies widely by state. This article assesses the effects of changes in Medicaid benefit policies, general tobacco policies, smoking norms, and public health programs on the use of cessation therapy among Medicaid smokers. METHODS: We used longitudinal panel analysis, using 2-way fixed effects models, to examine the effects of changes in state policies and characteristics on state-level use of Medicaid tobacco cessation medications from 2010 through 2014...
October 27, 2016: Preventing Chronic Disease
Karma McKelvey, Johannes Thrul, Danielle Ramo
BACKGROUND: Historically, smoking cessation was thought to negatively impact substance use outcomes among smokers who use other substances. We sought to synthesize recent reports on this association. METHODS: Google Scholar, PubMed, and Cinahl were searched for studies published from 2006 to March 29, 2016 that reported impact of smoking cessation treatment or quitting smoking on substance use or substance use disorder treatment outcomes in the general population and among those in substance abuse treatment...
February 2017: Addictive Behaviors
Joseph E Chidiac, Ahmed Mohamed, Madhumitha Krishnamoorthy, Karim Mahmoud, Geethapriya Rajasekaranrathnakumar, Mohan Palla, Diane L Levine
INTRODUCTION: Hospital systems are adopting strict nicotine-free policies excluding hiring individuals who smoke, including residents for graduate medical training. This study was conducted to (1) determine medical schools' awareness of these policies, (2) awareness of their students' smoking behaviors, and (3) the smoking cessation programs that they provide. METHODS: A survey was developed to learn about the smoking policies of medical schools in the United States: how school leadership estimates smoking prevalence among their students, what those estimates are, and what programs are in place to help students quit smoking...
October 27, 2016: Nicotine & Tobacco Research: Official Journal of the Society for Research on Nicotine and Tobacco
Jennifer M Schindler-Ruwisch, Lorien C Abroms, Steven L Bernstein, Christina L Heminger
Government regulations have created new incentives for health systems to implement changes in electronic health records (EHRs) to reduce tobacco use among patients. The purpose of this study is to conduct a content analysis of EHR modifications aimed at supporting tobacco cessation and to document these modifications using a 5 A's framework (i.e., Ask, Advise, Assess, Assist, Arrange). Fourteen trials were identified that met inclusion criteria. A content analysis of EHR functionality in these trials was conducted by two independent reviewers between February and June 2015...
October 31, 2016: Translational Behavioral Medicine
Peter G Shields, Roy S Herbst, Douglas Arenberg, Neal L Benowitz, Laura Bierut, Julie Bylund Luckart, Paul Cinciripini, Bradley Collins, Sean David, James Davis, Brian Hitsman, Andrew Hyland, Margaret Lang, Scott Leischow, Elyse R Park, W Thomas Purcell, Jill Selzle, Andrea Silber, Sharon Spencer, Tawee Tanvetyanon, Brian Tiep, Hilary A Tindle, Reginald Tucker-Seeley, James Urbanic, Monica Webb Hooper, Benny Weksler, C Will Whitlock, Douglas E Wood, Jennifer Burns, Jillian Scavone
Cigarette smoking has been implicated in causing many cancers and cancer deaths. There is mounting evidence indicating that smoking negatively impacts cancer treatment efficacy and overall survival. The NCCN Guidelines for Smoking Cessation have been created to emphasize the importance of smoking cessation and establish an evidence-based standard of care in all patients with cancer. These guidelines provide recommendations to address smoking in patients and outlines behavioral and pharmacologic interventions for smoking cessation throughout the continuum of oncology care...
November 2016: Journal of the National Comprehensive Cancer Network: JNCCN
Angie Leon-Salas, Jamie J Hunt, Kimber P Richter, Niaman Nazir, Edward F Ellerbeck, Theresa I Shireman
OBJECTIVES: Rural smokers are more likely to be uninsured and live in poverty, which may pose significant cost barriers to accessing smoking cessation medications. As part of a randomized clinical trial, we provided support to connect low-income smokers with the use of pharmaceutical assistance programs (PAPs) to improve medication access. METHODS: Study participants were rural smokers enrolled in a randomized clinical trial testing in-office telemedicine versus telephone-based approaches to deliver counseling sessions...
January 2017: Journal of the American Pharmacists Association: JAPhA
Krishna P Reddy, Robert A Parker, Elena Losina, Travis P Baggett, A David Paltiel, Nancy A Rigotti, Milton C Weinstein, Kenneth A Freedberg, Rochelle P Walensky
BACKGROUND:  In the United States, >40% of people infected with human immunodeficiency virus (HIV) smoke cigarettes. METHODS:  We used a computer simulation of HIV disease and treatment to project the life expectancy of HIV-infected persons, based on smoking status. We used age- and sex-specific data on mortality, stratified by smoking status. The ratio of the non-AIDS-related mortality risk for current smokers versus that for never smokers was 2.8, and the ratio for former smokers versus never smokers was 1...
December 1, 2016: Journal of Infectious Diseases
Kindred K Harris, Mohan Zopey, Theodore C Friedman
No abstract text is available yet for this article.
November 2016: Nature Reviews. Endocrinology
Stefano Fogli, Alessandro Saba, Marzia Del Re, Francesco Pistelli, Ferruccio Aquilini, Riccardo Zucchi, Antonio Palla, Maria Cristina Breschi, Laura Carrozzi, Romano Danesi
The nicotine metabolite ratio, i.e., the ratio 3-hydroxycotinine/cotinine, is used to assess the nicotine metabolic status and has been proven to predict the response to smoking cessation treatments in randomized clinical trials. In the current study, a pharmacokinetic-pharmacogenetic integrated approach is described, based on the development of a liquid chromatography-tandem mass spectrometry (LC/MS/MS) method for nicotine metabolite ratio assay in plasma and a real-time PCR analysis for fast genotyping of CYP2A6...
November 30, 2016: Journal of Pharmaceutical and Biomedical Analysis
2016-11-08 22:02:21
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"